Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort.
Alexander PeikertKlaus KaierJulian MerzLucas ManhartIbrahim SchäferIngo HilgendorfPhilipp HehnDennis WolfFlorian WilleckeXia ShengAndreas ClemensManfred ZehenderConstantin von Zur MühlenChristoph BodeAndreas ZirlikPeter StachonPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2019)
One-third of all-comers patients with CHD showed increased levels of hsCRP despite a LDL-cholesterol < 70 mg/dl potentially qualifying for an anti-inflammatory therapy. Elevated proBNP is an independent risk factor for hsCRP elevation.